Close

Anti-CBX3 DNA-encoded mAb (DMAb), pVAX1 (DMAb-1117-YY)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product is the plasmid containing an encoded anti-CBX3 DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.

  Add to Cart

Specifications

  • Target
  • CBX3
  • Vector Name
  • pVAX1
  • Vector Description
  • pVAX1 was originally designed for the development of DNA vaccines. Its eukaryotic DNA sequences limited to the expression of desired sequence so that minimize the possibility of chromosomal integration. This vector has been widely used for the construction of DMAb plasmid.
  • Vector Promoter
  • CMV
  • Vector Tag or Fusion
  • Untagged
  • Delivery Method
  • Transfection
  • Cloning Method
  • Restriction Enzyme ⁄ MCS
  • Constitutive or Inducible System
  • Constitutive
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term.
  • Background
  • DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics.

Target

Sub CAT. DMAb Clone DMAb Host Target Species DMAb Isotype DMAb Immunogen  
DMAb-1117-YY CBYY-C1038 Mouse Human Recombinant protein corresponding to human CBX3 expressed in E. coli
DMAb-1118-YY CBYY-C1039 Mouse Human IgG1 Recombinant fragment of human CBX3 expressed in E. Coli
DMAb-0730-FY CBFYH-0050 Mouse Human IgG 29-86 of 183 of CBX3 Protein
DMAb-0778-FY CBFYH-2920 Mouse Human IgG1 Recombinant HP1-gamma mouse
DMAb-0779-FY CBFYH-2921 Mouse Human IgG1
DMAb-0780-FY CBFYH-2922 Rat Human IgM Full length recombinant protein
DMAb-0781-FY CBFYH-0043 Mouse Human IgG1 Recognizes mouse Heterochromatin protein-1 gamma at ~22kD. Species Crossreactivity: human, rat.
DMAb-0782-FY CBFYH-0044 Mouse Human IgG1 Recombinant mouse HP1gamma
DMAb-0783-FY CBFYH-0045 Mouse Human IgG1 Fusion protein corresponding to aa17-173 of human Heterochromatin Protein 1 gamma with GST
DMAb-0784-FY CBFYH-0046 Mouse Human IgG
DMAb-0785-FY CBFYH-0047 Mouse Human Recombinant protein
DMAb-0786-FY CBFYH-0048 Mouse Human
DMAb-0787-FY CBFYH-0049 Mouse Human IgG1 114-173 of 183 of CBX3 Protein
DMAb-0788-FY CBFYH-0051 Mouse Human
DMAb-0789-FY CBFYH-0052 Rabbit Human IgG
DMAb-0790-FY CBFYH-0053 Rabbit Human IgG
DMAb-0791-FY CBFYH-0054 Mouse Human IgG1 Purified recombinant human HP1-gamma protein fragments expressed in E.coli
DMAb-0792-FY CBFYH-0055 Mouse Human IgG2a
DMAb-2680-FY CBFYC-0898 Mouse Human IgG2a
DMAb-2681-FY CBFYC-0899 Mouse Human IgG2a, k
DMAb-2682-FY CBFYC-0900 Mouse Human IgG2a, k Full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
DMAb-1749-FY CBFYM-0898 Rat Human IgM This item recognises the M32 molecule in mouse and the HP1 HS gamma molecule in man
DMAb-0135-CQ CBXC-0101 Mouse IgG1
DMAb-0136-CQ CBXC-0099 Mouse IgG2a, κ
DMAb-0137-CQ CBXC-0100 Mouse IgG2a, κ
DMAb-0138-CQ CBXC-2953 Mouse IgG1 Purified recombinant human HP1-gamma protein fragments expressed in E. coli

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-CBX3 DNA-encoded mAb (DMAb), pVAX1 (DMAb-1117-YY). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.